Barclays lowered the firm’s price target on Novo Nordisk (NVO) to DKK 700 from DKK 900 and keeps an Overweight rating on the shares.Stay Ahead ...

As detailed by Reuters, Novo Nordisk announced in February that it saw a 23% increase in heat-trapping pollution last year, and it expects that percentage to climb as it churns out more of the weight ...

LONDON/COPENHAGEN (Reuters) - Novo Nordisk's head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish drugmaker said on Thursday. Novo's rare ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus ® (oral semaglutide) significantly reduced the risk of major adverse ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results but remains strong in diabetes treatment, insulin, and GLP-1 products. I outline the bull case ...

Morgan Wallen’s second stint as musical guest on “Saturday Night Live” is stirring some controversy among viewers. On Saturday, March 29, Oscar winner Mikey Madison hosted the late-night ...

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for it to become a new treatment option for people living with ...

BALTIMORE (WBFF) — Celebrating their "29th birthday," the Baltimore Ravens have unveiled a commemorative logo and announced a series of fan engagements to mark the beginning of their 30th NFL ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults with type 2 diabetes. A regulatory decision is anticipated in 2025. Rybelsus, ...

Novo Nordisk (NVO) closed the most recent trading day at $69.30, moving -1.23% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.97%.

Finally, on the lighting tab, you can choose how bright you want the illuminated Razer logo on the front, as well as the RGB keyboard, on both battery and while charging. This is also where you ...

(RTTNews) - Lexicon Pharmaceuticals, Inc. (LXRX) announced Friday that it has entered into an exclusive license agreement with Novo Nordisk A/S for LX9851, a first-in-class, oral non-incretin ...